highperformr logo

Aclaris Therapeutics, Inc.'s Overview

Total employees53
HeadquartersWayne
Founded2012

Aclaris Therapeutics, Inc. (NASDAQ: ACRS) is a clinical-stage biopharmaceutical company committed to developing novel, optimized therapies for immuno-inflammatory diseases. Their focus is on identifying and advancing drug candidates that have the potential to address significant unmet medical needs. Aclaris leverages its scientific expertise to build a pipeline of innovative treatments, primarily in areas such as rheumatology and other autoimmune conditions. The company is dedicated to rigorous scientific research and clinical development to bring new therapeutic options to patients.

Where is Aclaris Therapeutics, Inc.'s Headquarters?

HQ Function

Serves as the central hub for corporate administration, clinical development leadership, research strategy, business development, and financial operations.

Notable Features:

Modern office and potentially laboratory facilities designed to support biopharmaceutical research and development. The space is likely configured to foster collaboration among scientific, clinical, and administrative teams.

Work Culture:

Aclaris fosters a dynamic, science-driven work environment focused on innovation, collaboration, and a commitment to addressing unmet medical needs. The culture emphasizes scientific excellence, agility, and a patient-centric approach, typical of a clinical-stage biotech company.

HQ Significance:

The headquarters is pivotal for Aclaris's mission, housing key decision-makers and the core infrastructure for advancing its pipeline of novel therapies. Its location in the Greater Philadelphia area places it within a prominent pharmaceutical and biotechnology hub, facilitating access to talent and industry networks.

Values Reflected in HQ: The headquarters' design and operations aim to reflect Aclaris's core values of scientific rigor, innovation, integrity, collaboration, and a strong patient focus in their pursuit of therapeutic advancements.

Location:

Aclaris Therapeutics primarily operates from its US headquarters in Wayne, Pennsylvania. Its global presence is mainly characterized by the execution of clinical trials in various international locations as required for its drug development programs. The company also engages with the global scientific and medical community through research collaborations, presentations at international conferences, and partnerships to advance its immuno-inflammatory disease therapies.

Street Address:

640 Lee Road, Suite 200

City:

Wayne

State/Province:

PA

Country:

USA

Aclaris Therapeutics, Inc.'s Global Presence

Buying Intent Signals for Aclaris Therapeutics, Inc.

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Aclaris Therapeutics, Inc.

As of April 2025, Aclaris Therapeutics, Inc.' leadership includes:

Douglas J. Manion, M.D. - Chief Executive Officer & President
Kevin Bodic - Chief Financial Officer
Joseph Monahan, Ph.D. - Chief Scientific Officer
Gail Cawkwell, M.D., Ph.D. - Chief Medical Officer
Robert A. Dalesandro - Chief Business and Strategy Officer
Neal Walker, D.O. - Founder, Chairman of the Board

Investors of Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. has been backed by several prominent investors over the years, including:

BlackRock Inc.
The Vanguard Group, Inc.
Renaissance Technologies LLC
State Street Corporation
Geode Capital Management, LLC
Point72 Asset Management, L.P.

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits0

Aclaris Therapeutics strengthened its executive team with a key appointment in business and strategy over the past year, reflecting its focus on advancing its clinical pipeline and strategic growth initiatives. No major C-level departures were publicly announced during this period.

New Appointments:

Robert A. Dalesandro, Robert A. Dalesandro appointed as Chief Business and Strategy Officer to lead business development and corporate strategy efforts.

Technology (Tech Stack) used by Aclaris Therapeutics, Inc.

Discover the tools Aclaris Therapeutics, Inc. uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Aclaris Therapeutics, Inc. Email Formats and Examples

Aclaris Therapeutics Inc. commonly uses the 'firstinitiallast' email format for its employees. Other formats might exist but this is understood to be a prevalent one.

[first_initial][last]@aclaristx.com

Format

jdoe@aclaristx.com

Example

85%

Success rate

News and media

GlobeNewswireMay 7, 2024

Aclaris Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update

Aclaris announced its financial results for the first quarter ended March 31, 2024, and provided updates on its clinical programs, including progress on ATI-1777 and ATI-2138....more

GlobeNewswireFebruary 27, 2024

Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update

Aclaris reported its financial results for the fourth quarter and full year 2023, highlighting clinical advancements and outlining strategic priorities for its development pipeline....more

GlobeNewswireJanuary 4, 2024

Aclaris Therapeutics Provides Update on ATI-1777 Phase 2b Study in Atopic Dermatitis

Aclaris announced that its Phase 2b study of ATI-1777 for atopic dermatitis did not meet its primary endpoint, leading to a strategic decision to discontinue development of ATI-1777 for this indication and to explore strategic alternatives for the asset....more

GlobeNewswireSeptember 7, 2023

Aclaris Therapeutics Appoints Robert A. Dalesandro as Chief Business and Strategy Officer

Aclaris announced the appointment of Robert A. Dalesandro as its new Chief Business and Strategy Officer, effective September 5, 2023....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Aclaris Therapeutics, Inc., are just a search away.